Brompheniramine and codeine and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Brompheniramine and codeine and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / codeine
Brand name: EndaCof-AC, Nalex AC
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Brompheniramine and codeine-Insulin degludec
- Brompheniramine and codeine-Insulin Degludec (U-100) Prefilled Pens
- Brompheniramine and codeine-Insulin Degludec (U-100) Vials
- Brompheniramine and codeine-Insulin Degludec (U-200) Prefilled Pens
- Brompheniramine and codeine-Insulin degludec and liraglutide
- Brompheniramine and codeine-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and phenylephrine
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and Phenylephrine Chewable Tablets
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and Phenylephrine Liquid
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and Phenylephrine Suspension
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and Phenylephrine Tablets
- Insulin aspart, recombinant Subcutaneous-Brompheniramine and pseudoephedrine